{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:51:00Z","timestamp":1780973460130,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.thromres.2015.04.005","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T20:17:27Z","timestamp":1428783447000},"page":"1110-1116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case\u2013control study"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6126-2528","authenticated-orcid":false,"given":"Aneel A.","family":"Ashrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel K.","family":"Barsoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Crusan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Petterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent R.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Heit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2015.04.005_bb0005","series-title":"Hurst's The Heart","first-page":"1215","article-title":"Atherothrombosis: Disease burden, activity, and vulnerability","author":"Falk","year":"2011"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0049-3848(97)00192-8","article-title":"Hypercholesterolemia as a risk factor for deep-vein thrombosis","volume":"88","author":"Kawasaki","year":"1997","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0015","first-page":"386","article-title":"Plasma lipoproteins, hemostasis and thrombosis","volume":"86","author":"Griffin","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2141.2002.03563.x","article-title":"Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors","volume":"118","author":"Vaya","year":"2002","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.thromres.2015.04.005_bb0025","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/jama.1997.03540320044033","article-title":"A prospective study of risk factors for pulmonary embolism in women","volume":"277","author":"Goldhaber","year":"1997","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.thromres.2015.04.005_bb0030","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1001\/archinte.162.10.1182","article-title":"Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology","volume":"162","author":"Tsai","year":"2002","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MBC.0b013e3282f54558","article-title":"Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry","volume":"19","author":"Linnemann","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"17","key":"10.1016\/j.thromres.2015.04.005_bb0040","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1161\/CIRCULATIONAHA.109.921460","article-title":"Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study","volume":"121","author":"Holst","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0021-9150(99)00485-2","article-title":"Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy","volume":"152","author":"de Man","year":"2000","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.thromres.2015.04.005_bb0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/09537100120058810","article-title":"Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia","volume":"12","author":"Pathansali","year":"2001","journal-title":"Platelets"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0021-9150(98)00037-9","article-title":"The atherogenic lipoprotein phenotype and vascular endothelial dysfunction","volume":"138","author":"Sattar","year":"1998","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.thromres.2015.04.005_bb0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1055\/s-0038-1642518","article-title":"Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet","volume":"71","author":"Bladbjerg","year":"1994","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0065","first-page":"69","article-title":"Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome","volume":"25","author":"Atsumi","year":"1998","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.thromres.2015.04.005_bb0070","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","article-title":"Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis","volume":"98","author":"Caplice","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archinte.1994.00420020066008","article-title":"Acquired risk factors for deep-vein thrombosis in symptomatic outpatients","volume":"154","author":"Cogo","year":"1994","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.thromres.2015.04.005_bb0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1046\/j.1365-2168.1999.01129.x","article-title":"Deep venous thrombosis in peripheral vascular disease","volume":"86","author":"Libertiny","year":"1999","journal-title":"Br J Surg"},{"issue":"15","key":"10.1016\/j.thromres.2015.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa022157","article-title":"An association between atherosclerosis and venous thrombosis","volume":"348","author":"Prandoni","year":"2003","journal-title":"N Engl J Med"},{"issue":"8934","key":"10.1016\/j.thromres.2015.04.005_bb0090","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.thromres.2015.04.005_bb0095","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.thromres.2015.04.005_bb0100","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-129-9-199811010-00002","article-title":"Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial","volume":"129","author":"Lewis","year":"1998","journal-title":"Ann Intern Med"},{"issue":"9245","key":"10.1016\/j.thromres.2015.04.005_bb0105","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0140-6736(00)03257-8","article-title":"Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study","volume":"356","author":"Tonkin","year":"2000","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.thromres.2015.04.005_bb0110","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0115","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0021-9150(00)00733-4","article-title":"Sustained long-term improvement of arterial endothelial function in heterozygous familial hypercholesterolemia patients treated with simvastatin","volume":"157","author":"Alonso","year":"2001","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0120","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1161\/hc2901.094094","article-title":"Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3days","volume":"104","author":"Tsunekawa","year":"2001","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.thromres.2015.04.005_bb0125","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"de Jongh","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/hc0402.104119","article-title":"Simvastatin preserves the structure of coronary adventitial vasa vasorum in experimental hypercholesterolemia independent of lipid lowering","volume":"105","author":"Wilson","year":"2002","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0135","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0021-9150(01)00645-1","article-title":"The effects of hydroxy-methyl-glutaryl co-enzyme A reductase inhibitors on platelet thrombus formation","volume":"161","author":"Thompson","year":"2002","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0140","first-page":"23","article-title":"Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia","volume":"13","author":"Ma","year":"2002","journal-title":"J Assoc Acad Minor Phys"},{"issue":"12","key":"10.1016\/j.thromres.2015.04.005_bb0145","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-dependent effect of statins on platelet function in hypercholesterolaemia","volume":"32","author":"Puccetti","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"18","key":"10.1016\/j.thromres.2015.04.005_bb0150","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/01.CIR.103.18.2248","article-title":"Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation","volume":"103","author":"Undas","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.17.2.265","article-title":"Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis","volume":"17","author":"Colli","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0160","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.ATV.0000012802.69414.A8","article-title":"Fluvastatin reduces tissue factor expression and macrophage accumulation in carotid lesions of cholesterol-fed rabbits in the absence of lipid lowering","volume":"22","author":"Baetta","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0165","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1055\/s-0037-1613075","article-title":"Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin","volume":"87","author":"Camera","year":"2002","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2015.04.005_bb0170","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.12223","article-title":"Statin therapy and levels of hemostatic factors in a healthy population: the Multi-Ethnic Study of Atherosclerosis","volume":"11","author":"Adams","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation\/CRP evaluation (PRINCE): a randomized trial and cohort study","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.thromres.2015.04.005_bb0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0953-6205(01)00172-8","article-title":"Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein","volume":"12","author":"van Haelst","year":"2001","journal-title":"Eur J Intern Med"},{"issue":"20","key":"10.1016\/j.thromres.2015.04.005_bb0185","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/jama.279.20.1643","article-title":"Antiatherothrombotic properties of statins: implications for cardiovascular event reduction","volume":"279","author":"Rosenson","year":"1998","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.thromres.2015.04.005_bb0190","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/s-0037-1613893","article-title":"Pravastatin: an antithrombotic effect independent of the cholesterol-lowering effect","volume":"83","author":"Dangas","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0195","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0049-3848(02)00034-8","article-title":"Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease","volume":"105","author":"Seljeflot","year":"2002","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.thromres.2015.04.005_bb0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-132-9-200005020-00002","article-title":"Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen\/progestin Replacement Study","volume":"132","author":"Grady","year":"2000","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.thromres.2015.04.005_bb0205","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/01.CIR.0000019406.74017.B2","article-title":"Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen\/Progestin Replacement Study (HERS)","volume":"105","author":"Herrington","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.thromres.2015.04.005_bb0210","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.161.11.1405","article-title":"Use of statins and the subsequent development of deep vein thrombosis","volume":"161","author":"Ray","year":"2001","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.thromres.2015.04.005_bb0215","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/j.1538-7836.2004.00696.x","article-title":"HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women","volume":"2","author":"Doggen","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0220","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1472-8206.2004.00252.x","article-title":"Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case\u2013control study","volume":"18","author":"Lacut","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.thromres.2015.04.005_bb0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","author":"Huerta","year":"2007","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1538-7836.2008.03235.x","article-title":"HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis","volume":"7","author":"Ramcharan","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"18","key":"10.1016\/j.thromres.2015.04.005_bb0235","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0240","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2009.03279.x","article-title":"Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case\u2013control study","volume":"7","author":"Sorensen","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.thromres.2015.04.005_bb0245","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-1241.2010.02439.x","article-title":"Statin use and the prevention of venous thromboembolism: a meta-analysis","volume":"64","author":"Agarwal","year":"2010","journal-title":"Int J Clin Pract"},{"issue":"10","key":"10.1016\/j.thromres.2015.04.005_bb0250","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/eurheartj\/ehp556","article-title":"Statins, fibrates, and venous thromboembolism: a meta-analysis","volume":"31","author":"Squizzato","year":"2010","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.thromres.2015.04.005_bb0255","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.thromres.2011.05.012","article-title":"Statins in the prevention of venous thromboembolism: a meta-analysis of observational studies","volume":"128","author":"Pai","year":"2011","journal-title":"Thromb Res"},{"issue":"24","key":"10.1016\/j.thromres.2015.04.005_bb0260","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1136\/heartjnl-2012-302906","article-title":"Adherence to statins is associated with reduced incidence of idiopathic venous thromboembolism: real-life data from a large healthcare maintenance organisation","volume":"98","author":"Rabinowich","year":"2012","journal-title":"Heart"},{"issue":"24","key":"10.1016\/j.thromres.2015.04.005_bb0265","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/eurheartj\/eht046","article-title":"Statin treatment and the risk of recurrent pulmonary embolism","volume":"34","author":"Biere-Rafi","year":"2013","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.thromres.2015.04.005_bb0270","doi-asserted-by":"crossref","first-page":"e003135","DOI":"10.1136\/bmjopen-2013-003135","article-title":"Statin treatment and risk of recurrent venous thromboembolism: a nationwide cohort study","volume":"3","author":"Nguyen","year":"2013","journal-title":"BMJ Open"},{"issue":"8","key":"10.1016\/j.thromres.2015.04.005_bb0275","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1111\/jth.12604","article-title":"Statin use and venous thromboembolism recurrence: a combined nationwide cohort and nested case\u2013control study","volume":"12","author":"Schmidt","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0280","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0306-5251.2001.01523.x","article-title":"Statins and the risk of idiopathic venous thromboembolism","volume":"53","author":"Yang","year":"2002","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.thromres.2015.04.005_bb0285","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2125.2008.03308.x","article-title":"Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials","volume":"67","author":"Smeeth","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.thromres.2015.04.005_bb0290","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database","volume":"340","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2015.04.005_bb0295","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2318-11-8","article-title":"Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)","volume":"11","author":"Freeman","year":"2011","journal-title":"BMC Geriatr"},{"issue":"6","key":"10.1016\/j.thromres.2015.04.005_bb0300","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.thromres.2012.08.296","article-title":"Lipid lowering drugs and the risk of recurrent venous thromboembolism","volume":"130","author":"Delluc","year":"2012","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.thromres.2015.04.005_bb0305","doi-asserted-by":"crossref","first-page":"e1001310","DOI":"10.1371\/journal.pmed.1001310","article-title":"Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials","volume":"9","author":"Rahimi","year":"2012","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0310","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.1975.03240160024021","article-title":"Clofibrate and niacin in coronary heart disease","volume":"231","year":"1975","journal-title":"JAMA"},{"issue":"9500","key":"10.1016\/j.thromres.2015.04.005_bb0315","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","author":"Keech","year":"2005","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.thromres.2015.04.005_bb0320","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.thromres.2015.04.005_bb0325","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.thromres.2015.04.005_bb0330","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4065\/71.3.266","article-title":"History of the Rochester Epidemiology Project","volume":"71","author":"Melton","year":"1996","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.thromres.2015.04.005_bb0335","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","author":"Silverstein","year":"1998","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.thromres.2015.04.005_bb0340","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V106.11.1618.1618","article-title":"Novel Risk Factors for Venous Thromboembolism (VTE): A Population-Based Case\u2013control Study","volume":"106","author":"Heit","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.thromres.2015.04.005_bb0345","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case\u2013control study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"issue":"9","key":"10.1016\/j.thromres.2015.04.005_bb0350","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/ATVBAHA.109.189290","article-title":"Is diabetes mellitus an independent risk factor for venous thromboembolism?: a population-based case\u2013control study","volume":"29","author":"Heit","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.thromres.2015.04.005_bb0355","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.thromres.2010.08.010","article-title":"Is progestin an independent risk factor for incident venous thromboembolism? A population-based case\u2013control study","volume":"126","author":"Barsoum","year":"2010","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.thromres.2015.04.005_bb0360","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/scientificamerican1081-54","article-title":"The patient record in epidemiology","volume":"245","author":"Kurland","year":"1981","journal-title":"Sci Am"},{"issue":"9","key":"10.1016\/j.thromres.2015.04.005_bb0365","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/aje\/kwq482","article-title":"Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project","volume":"173","author":"St Sauver","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.thromres.2015.04.005_bb0370","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mayocp.2011.11.009","article-title":"Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project","volume":"87","author":"St Sauver","year":"2012","journal-title":"Mayo Clin Proc"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T20:03:25Z","timestamp":1598904205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S0049384815001607"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.04.005","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}